YOUR DEDICATED TEAM PROVIDES SUPPORT FOR YOU AND YOUR PATIENTS

BROADLY COVERED AND AFFORDABLE FOR MOST PATIENTS^2*

Because it is given by an HCP, LEQVIO^® is covered primarily under the medical benefit, not the pharmacy benefit

COVERED, AFFORDABLE

NO PRIOR AUTHORIZATION REQUIRED

COVERED

Most patients pay 36% LESS^† FOR LEQVIO vs other branded nonstatin treatments^2‡

• Based on 2100+ medical and pharmacy claims, excluding low-income subsidy patients

• Patient monthly OOPs represent actual yearly cost divided by 12 to reflect an average monthly cost

AFFORDABLE

Approval rates for LEQVIO^® are higher when claims are submitted appropriately under the medical benefit^2¶

• Based on 2100+ medical and pharmacy claims, excluding low-income subsidy patients

*Coverage information is subject to change by the relevant plan and is based on data up to July 2023. The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims.^2 
†The comparison pertains only to differences in cost and should not be considered a comparison of efficacy or safety.^2
‡Branded nonstatin treatments include Repatha^®, Nexlizet^®, Nexletol^®, and Praluent^®.
^§Patient out-of-pocket cost calculated from annualized medical and pharmacy claims. Monthly out-of-pocket per brand is based on weighted average of prescribed dose per patient. Data current as of July 2023.
^¶Includes Traditional Medicare, Medicare Advantage, and Commercial plans.
All trademarks are the property of their respective owners.

Eligible privately insured patients may pay as little as $0 for LEQVIO with the co-pay savings offer. Subject to terms and conditions. Limitations apply.^#

Eligible privately insured new patients may be able to receive up to two (2) free doses if coverage is delayed or denied. Limitations apply.**

LEQVIO Care Program

www.careprogram.leqvio.com | 1-833-LEQVIO2

When enrolled, patients on therapy have access to:

• One-on-one support by LEQVIO Care Specialists

• Injection appointment reminders

• Helpful tools, lifestyle tips, and motivation through text, mail, and email

The LEQVIO Care Program is a patient support program and is not intended to take the place of medical or clinical advice from a health care provider.

^#Eligible patients must have commercial insurance, a valid prescription for LEQVIO, and a prior authorization that has been denied or pending for greater than 3 calendar days. Program provides up to two (2) doses of free medication. Program is not available to patients who are uninsured or whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program, or where prohibited by law. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Other limitations may apply. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

**Limitations apply. Valid only for those with commercial insurance. The Program may include the Co-pay Card, Payment Card (if applicable), and Rebate. Per treatment maximums and an annual benefit cap apply. For patients covered under the medical benefit, rebate for out-of-pocket costs will be assigned directly to provider, unless patient requests direct reimbursement. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient's insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient's insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

You can enroll your patients 3 different ways:

THE CHOICE IS YOURS

Flexible pathways for acquisition and administration

BUY-AND-BILL

Administration takes place in your office (Medical Benefit)

• Buy-and-bill is an option for acquiring drugs covered under the medical benefit that are administered by a health care provider

• Drugs covered under Medicare Part B (fee-for-service) must be acquired through this method

SPECIALTY PHARMACY

Administration takes place within your office via an SP

• A patient’s plan may restrict drug coverage under the pharmacy benefit using an SP

• LEQVIO ordered through an SP must be given to the specific patient for whom it was ordered (unlike the buy-and-bill, in which LEQVIO can be given to any patient for whom it’s prescribed)

ALTERNATE SITE OF CARE

Administration takes place at a site other than your office*

Practice locates and refers the patient to an Alternate Site of Care, which then handles the following:

• Benefits verification

• Prior authorization support

• Acquisition of LEQVIO

• Administration of LEQVIO

• Submitting claims for reimbursement

A system hospital outpatient department (HOPD) may act as an Alternate Site of Care. It's important to understand system requirements before sending the LEQVIO patient to that facility